Article info

Download PDFPDF
Letter
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

Authors

  1. Correspondence to Prof. Massimiliano Di Filippo, Clinica Neurologica, Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, IT, University of Perugia, Perugia, Umbria, Italy; massimiliano.difilippo{at}unipg.it
View Full Text

Citation

Di Filippo M, Cordioli C, Malucchi S On behalf of the RIREMS (Rising Researchers in MS) group, et al
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

Publication history

  • Received May 21, 2021
  • Accepted August 8, 2021
  • First published August 18, 2021.
Online issue publication 
March 14, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.